Related Experiment Video
Updated: Feb 6, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Enzyme therapy for functional bowel disease-like post-prandial distress
David Y Graham1,2, Gyanprakash A Ketwaroo1,2, Mary E Money3,4
1Department of Medicine, Michael E. DeBakey VA Medical Center, Houston, Texas.
Multi-digestive enzymes show promise for managing post-prandial gastrointestinal symptoms, including diarrhea, consistent with irritable bowel syndrome. Further research with validated scoring systems is recommended to confirm efficacy and identify optimal enzyme combinations.
Area of Science:
- Gastroenterology
- Digestive Health
- Clinical Nutrition
Background:
- Post-prandial gastrointestinal symptoms like diarrhea, bloating, and flatulence are common but often lack clear causes.
- Digestive enzyme supplements have a historical precedent for alleviating these symptoms, supported by numerous trials.
Purpose of the Study:
- To review studies on multi-digestive enzyme use for symptoms aligning with irritable bowel syndrome (IBS).
- To examine clinical trials, including randomized placebo-controlled studies, focusing on post-prandial diarrhea and IBS-D.
Main Methods:
- Narrative review of clinical trials over the past 60 years.
- Inclusion of double-blinded, randomized, placebo-controlled studies.
- Exclusion of studies focusing solely on disaccharidase or other specific carbohydrate enzyme deficiencies.
Main Results:
- Worldwide studies generally report positive outcomes with multi-enzyme preparations for post-prandial symptoms.
- No studies utilized factorial designs to pinpoint specific effective enzyme subgroups or link symptoms to components.
Conclusions:
- Multi-enzyme preparations have a history of success in managing post-prandial symptoms suggestive of IBS.
- Long-term studies with validated scoring and factorial designs are necessary to confirm efficacy for specific symptoms and components.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...

